Select Medical Holdings (SEM) Net Income towards Common Stockholders (2018 - 2025)
Select Medical Holdings (SEM) has disclosed Net Income towards Common Stockholders for 8 consecutive years, with -$273.6 million as the latest value for Q4 2025.
- On a quarterly basis, Net Income towards Common Stockholders fell 22.63% to -$273.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.1 billion, a 1182.37% decrease, with the full-year FY2025 number at -$96.8 million, down 17.84% from a year prior.
- Net Income towards Common Stockholders was -$273.6 million for Q4 2025 at Select Medical Holdings, up from -$277.8 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $196.2 million in Q2 2021 to a low of -$277.8 million in Q3 2025.
- A 5-year average of -$38.7 million and a median of $29.6 million in 2023 define the central range for Net Income towards Common Stockholders.
- Peak YoY movement for Net Income towards Common Stockholders: skyrocketed 568.35% in 2024, then crashed 806.33% in 2025.
- Select Medical Holdings' Net Income towards Common Stockholders stood at $66.3 million in 2021, then tumbled by 313.8% to -$141.8 million in 2022, then fell by 29.1% to -$183.0 million in 2023, then fell by 21.9% to -$223.1 million in 2024, then decreased by 22.63% to -$273.6 million in 2025.
- Per Business Quant, the three most recent readings for SEM's Net Income towards Common Stockholders are -$273.6 million (Q4 2025), -$277.8 million (Q3 2025), and -$265.8 million (Q2 2025).